透析患者心脏性猝死:不同病因与管理策略
欧洲透析工作组综述透析患者心脏性猝死的病因与管理。透析间期心脏性猝死与透析中心脏骤停应区分;前者左室射血分数降低仅见于少数,致命心律失常可能更多为缓慢性;后者可调节因素包括透析液钾钙浓度低,透析中心配置自动体外除颤器有获益证据。
要点
- 透析间期心脏性猝死与透析中心脏骤停是不同临床情况,应分开评估。
- 透析中心脏骤停可调节因素包括透析液钾、钙浓度低,透析中心配置自动体外除颤器有获益。
- 透析间期心脏性猝死仅少数伴左室射血分数降低,致命心律失常可能更多为缓慢性。
核心结论
- 透析间期心脏性猝死与透析中心脏骤停是不同临床情况,应保持区分。
- 透析间期心脏性猝死仅少数伴左室射血分数降低,致命心律失常可能更多为缓慢性,或可解释植入式心律转复除颤器未能显示预防优势。
- 电解质失衡可能解释部分心律失常现象,但腹膜透析患者心脏性猝死高发提示心脏合并症与尿毒症本身的其他危险因素也参与。
研究设计与样本
- 欧洲透析工作组(ERA-EDTA)对现有文献进行批判性综述,探讨终末期肾病患者透析间期心脏性猝死与透析中心脏骤停的病因及潜在管理策略。
主要发现
- 透析中心脏骤停可调节危险因素包括透析液钾浓度低和钙浓度低,透析中心配置自动体外除颤器有获益证据。
- 透析间期心脏性猝死仅少数伴左室射血分数降低,提示其与缺血性心脏病和/或心力衰竭患者的猝死特征不同。
- 近期证据提示该人群致命心律失常可能更多为缓慢性而非快速性。
- 心脏性猝死与血液透析时程的关系提示电解质失衡可能解释部分心律失常现象。
- 腹膜透析患者心脏性猝死高发提示心脏合并症与尿毒症本身的其他危险因素也参与。
关键数值与推荐
- 透析中心脏骤停的可调节危险因素包括透析液钾浓度低和钙浓度低。
- 透析中心配置自动体外除颤器与临床获益相关。
- 多项研究未能证明植入式心律转复除颤器在终末期肾病患者中预防心脏性猝死有优势。
临床怎么用
- 临床应区分透析间期心脏性猝死与透析中心脏骤停,分别评估危险因素与管理。
- 对透析中心脏骤停,关注透析液钾、钙浓度并考虑透析中心配置自动体外除颤器。
- 对透析间期心脏性猝死,不应仅以左室射血分数降低评估风险,需考虑缓慢性心律失常与电解质失衡。
局限性
- 心脏性猝死发生率精确估计困难,因研究常与透析中心脏骤停合并报告。
- 本文为叙述性综述,未提供原始研究数据或定量合并结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sudden cardiac death (SCD) represents a major cause of death in end-stage kidney disease (ESKD). The precise estimate of its incidence is difficult to establish because studies on the incidence of SCD in ESKD are often combined with those related to sudden cardiac arrest (SCA) occurring during a haemodialysis (HD) session. The aim of the European Dialysis Working Group of ERA-EDTA was to critically review the current literature examining the causes of extradialysis SCD and intradialysis SCA in ESKD patients and potential management strategies to reduce the incidence of such events. Extradialysis SCD and intradialysis SCA represent different clinical situations and should be kept distinct. Regarding the problem, numerically less relevant, of patients affected by intradialysis SCA, some modifiable risk factors have been identified, such as a low concentration of potassium and calcium in the dialysate, and some advantages linked to the presence of automated external defibrillators in dialysis units have been documented. The problem of extra-dialysis SCD is more complex. A reduced left ventricular ejection fraction associated with SCD is present only in a minority of cases occurring in HD patients. This is the proof that SCD occurring in ESKD has different characteristics compared with SCD occurring in patients with ischaemic heart disease and/or heart failure and not affected by ESKD. Recent evidence suggests that the fatal arrhythmia in this population may be due more frequently to bradyarrhythmias than to tachyarrhythmias. This fact may partly explain why several studies could not demonstrate an advantage of implantable cardioverter defibrillators in preventing SCD in ESKD patients. Electrolyte imbalances, frequently present in HD patients, could explain part of the arrhythmic phenomena, as suggested by the relationship between SCD and timing of the HD session. However, the high incidence of SCD in patients on peritoneal dialysis suggests that other risk factors due to cardiac comorbidities and uraemia per se may contribute to sudden mortality in ESKD patients.
引用
- Genovesi S, Boriani G, Covic A, et al. Sudden cardiac death in dialysis patients: different causes and management strategies. Nephrol Dial Transplant. 2021. PMID: 31538192. doi:10.1093/ndt/gfz182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。